Ovalo, Arthur S.
HRN: 21-28-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/22/2022
04/29/2022
IV
500mg
Q8H
Acute Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes